ESCALON (@escalonliver) 's Twitter Profile
ESCALON

@escalonliver

A H2020 research collaboration between Europe and Latin America developing cost-effective tools for the early diagnosis of hepatobiliary cancers

ID: 1360253808534818819

linkhttp://escalon.eu/ calendar_today12-02-2021 15:46:06

93 Tweet

88 Followers

84 Following

Jose Debes MD PhD (@josedebesmd) 's Twitter Profile Photo

Local but important work on HBV in Argentina by our awesome collaborators Belén Pisano & V. Re Genotype variation between acute and chronic HBV, HIV+ & -, mutation variants and HDV gt seems to matter! Acute and chronic HBV infection in central Argentina: pubmed.ncbi.nlm.nih.gov/36698842/

Local but important work on HBV in Argentina by our awesome collaborators <a href="/belupisano/">Belén Pisano</a> &amp; V. Re
Genotype variation between acute and chronic HBV, HIV+ &amp; -, mutation variants and HDV
gt seems to matter!
Acute and chronic HBV infection in central Argentina: pubmed.ncbi.nlm.nih.gov/36698842/
Cancers MDPI (@cancers_mdpi) 's Twitter Profile Photo

🏆Check out the Editor's Choice #Review "Serum Biomarkers for the Prediction of Hepatocellular Carcinoma" 👥Authors: Jose Debes MD PhD, Pablo A. Romagnoli et al. Erasmus MC IUCBC - Córdoba 🔗Link here: mdpi.com/2072-6694/13/7…

🏆Check out the Editor's Choice #Review "Serum Biomarkers for the Prediction of Hepatocellular Carcinoma"

👥Authors: <a href="/JoseDebesMD/">Jose Debes MD PhD</a>, <a href="/pabloromagnoli/">Pablo A. Romagnoli</a> et al. <a href="/ErasmusMC/">Erasmus MC</a> <a href="/IucbcI/">IUCBC - Córdoba</a>

🔗Link here: mdpi.com/2072-6694/13/7…
Jose Debes MD PhD (@josedebesmd) 's Twitter Profile Photo

Our ESCALON study validating GALAD for #HCC in Latin America and assessing ASAP score Hepatology Communications Interesting data on non-cirrhotic HCC Validation and optimization of AFP-based biomarkers for early HCC detection in Latin America and Europe pubmed.ncbi.nlm.nih.gov/37708457/

Our <a href="/EscalonLiver/">ESCALON</a> study validating GALAD for #HCC  in Latin America and assessing ASAP  score  <a href="/HepCommJournal/">Hepatology Communications</a> 
Interesting data on non-cirrhotic HCC 

Validation and optimization of AFP-based biomarkers for early HCC detection in Latin America and Europe pubmed.ncbi.nlm.nih.gov/37708457/
Jose Debes MD PhD (@josedebesmd) 's Twitter Profile Photo

Our study ESCALON showing no impact of STAT4 SNP on HCC risk in Hispanics...unless they identify of European ancestry. Key to assess ancestry! Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americanshttps://pubmed.ncbi.nlm.nih.gov/37760499/

Our study <a href="/EscalonLiver/">ESCALON</a> showing no impact of STAT4 SNP on HCC risk in Hispanics...unless they identify of European ancestry.
Key to assess ancestry! 

Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americanshttps://pubmed.ncbi.nlm.nih.gov/37760499/